Cargando…

Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication

OBJECTIVES: The amount of propofol required for intravenous sedation (IVS) in patients on long‐term oral benzodiazepine (BZD) therapy may be affected by drug interactions and central changes in sensitivity. However, there is no research on the effect of long‐term oral BZD use on the amount of propof...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujisawa, Toshiaki, Miyata, Kazuki, Nitta, Yukie, Terui, Akifumi, Ishikawa, Emi, Hamaya, Eri, Wakana, Keiichiro, Takuma, Shigeru, Shibuya, Makiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562837/
https://www.ncbi.nlm.nih.gov/pubmed/35719036
http://dx.doi.org/10.1002/cre2.601
_version_ 1784808264742993920
author Fujisawa, Toshiaki
Miyata, Kazuki
Nitta, Yukie
Terui, Akifumi
Ishikawa, Emi
Hamaya, Eri
Wakana, Keiichiro
Takuma, Shigeru
Shibuya, Makiko
author_facet Fujisawa, Toshiaki
Miyata, Kazuki
Nitta, Yukie
Terui, Akifumi
Ishikawa, Emi
Hamaya, Eri
Wakana, Keiichiro
Takuma, Shigeru
Shibuya, Makiko
author_sort Fujisawa, Toshiaki
collection PubMed
description OBJECTIVES: The amount of propofol required for intravenous sedation (IVS) in patients on long‐term oral benzodiazepine (BZD) therapy may be affected by drug interactions and central changes in sensitivity. However, there is no research on the effect of long‐term oral BZD use on the amount of propofol required for IVS. We aimed to clarify the difference between the total propofol dose required for IVS in patients with or without long‐term oral BZD therapy. MATERIAL AND METHODS: Among patients treated for 4 years, the total administered dose required for IVS with propofol alone and local anesthesia for the extraction of bilateral impacted mandibular wisdom teeth, was retrospectively compared between patients with continuous oral BZD use for ≥6 months (BZD group; n = 24) and those without such use (control group; n = 307). The aimed sedation level was the Ramsay sedation scale 3–4. RESULTS: The amount of propofol required for IVS was significantly lower in the BZD group compared to the control group (4.83 ± 1.30 vs. 5.91 ± 1.25 mg/kg/h, p < .001; 95% confidence interval, −1.22 to −0.94 mg/kg/h; Cohen's d, 0.84). The required propofol dose was not influenced by preoperative oral BZD administration on the day of extraction (presence [n = 13] vs. absence [n = 11]: 4.9 ± 1.3 vs. 4.8 ± 1.7 mg/kg/h, p = .83). Long‐term oral BZD therapy remained a significant factor for a lower required propofol dose after adjusting for age with multiple linear regression analysis. The underlying mechanism cannot be an additive action process but might pertain to competitive inhibition via an enzyme involved in glucuronate conjugation or competitive albumin binding. CONCLUSIONS: Clinicians should understand that patients on long‐term oral BZDs therapy might require less propofol for IVS than those not on BZDs, irrespective of whether BZDs were taken preoperatively on the day of surgery.
format Online
Article
Text
id pubmed-9562837
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95628372022-10-16 Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication Fujisawa, Toshiaki Miyata, Kazuki Nitta, Yukie Terui, Akifumi Ishikawa, Emi Hamaya, Eri Wakana, Keiichiro Takuma, Shigeru Shibuya, Makiko Clin Exp Dent Res Original Articles OBJECTIVES: The amount of propofol required for intravenous sedation (IVS) in patients on long‐term oral benzodiazepine (BZD) therapy may be affected by drug interactions and central changes in sensitivity. However, there is no research on the effect of long‐term oral BZD use on the amount of propofol required for IVS. We aimed to clarify the difference between the total propofol dose required for IVS in patients with or without long‐term oral BZD therapy. MATERIAL AND METHODS: Among patients treated for 4 years, the total administered dose required for IVS with propofol alone and local anesthesia for the extraction of bilateral impacted mandibular wisdom teeth, was retrospectively compared between patients with continuous oral BZD use for ≥6 months (BZD group; n = 24) and those without such use (control group; n = 307). The aimed sedation level was the Ramsay sedation scale 3–4. RESULTS: The amount of propofol required for IVS was significantly lower in the BZD group compared to the control group (4.83 ± 1.30 vs. 5.91 ± 1.25 mg/kg/h, p < .001; 95% confidence interval, −1.22 to −0.94 mg/kg/h; Cohen's d, 0.84). The required propofol dose was not influenced by preoperative oral BZD administration on the day of extraction (presence [n = 13] vs. absence [n = 11]: 4.9 ± 1.3 vs. 4.8 ± 1.7 mg/kg/h, p = .83). Long‐term oral BZD therapy remained a significant factor for a lower required propofol dose after adjusting for age with multiple linear regression analysis. The underlying mechanism cannot be an additive action process but might pertain to competitive inhibition via an enzyme involved in glucuronate conjugation or competitive albumin binding. CONCLUSIONS: Clinicians should understand that patients on long‐term oral BZDs therapy might require less propofol for IVS than those not on BZDs, irrespective of whether BZDs were taken preoperatively on the day of surgery. John Wiley and Sons Inc. 2022-06-19 /pmc/articles/PMC9562837/ /pubmed/35719036 http://dx.doi.org/10.1002/cre2.601 Text en © 2022 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Fujisawa, Toshiaki
Miyata, Kazuki
Nitta, Yukie
Terui, Akifumi
Ishikawa, Emi
Hamaya, Eri
Wakana, Keiichiro
Takuma, Shigeru
Shibuya, Makiko
Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication
title Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication
title_full Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication
title_fullStr Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication
title_full_unstemmed Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication
title_short Cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: A secondary publication
title_sort cross‐sectional study of propofol dose during intravenous sedation for dental surgery in patients with long‐term oral benzodiazepine therapy: a secondary publication
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562837/
https://www.ncbi.nlm.nih.gov/pubmed/35719036
http://dx.doi.org/10.1002/cre2.601
work_keys_str_mv AT fujisawatoshiaki crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT miyatakazuki crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT nittayukie crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT teruiakifumi crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT ishikawaemi crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT hamayaeri crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT wakanakeiichiro crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT takumashigeru crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication
AT shibuyamakiko crosssectionalstudyofpropofoldoseduringintravenoussedationfordentalsurgeryinpatientswithlongtermoralbenzodiazepinetherapyasecondarypublication